The quality of reporting of randomized controlled trials of intravitreal anti-VEGF therapy based on CONSORT statement

dc.contributor	Eberhard Karls Universität Tübingen	de_DE
dc.contributor.author	Stengele, Annette Laetitia	de_DE
dc.date.accessioned	2025-07-21T09:41:01Z
dc.date.available	2025-07-21T09:41:01Z
dc.date.issued	2025	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/168248
dc.identifier.uri	http://nbn-resolving.org/urn:nbn:de:bsz:21-dspace-1682486	de_DE
dc.identifier.uri	http://dx.doi.org/10.15496/publikation-109575
dc.language.iso	en
dc.publisher	Tübingen	de_DE
dc.title	The quality of reporting of randomized controlled trials of intravitreal anti-VEGF therapy based on CONSORT statement	de_DE
dc.type	PhDThesis	de_DE
utue.kommentar.intern	;;Dissertation, Eberhard Karls Universität Tübingen, 2025; Erscheint auch als, Online-Ausgabe, Stengele, Annette Laetitia, The quality of reporting of randomized controlled trials of intravitreal anti-VEGF therapy based on CONSORT statement, Tübingen, 2025, 1 Online-Ressource (88 Seiten),	de_DE
utue.personen.roh	Stengele, Annette Laetitia	de_DE
utue.publikation.seitengesamt	88 Seiten	de_DE
utue.titel.verfasserangabe	vorgelegt von Stengele, Annette Laetitia	de_DE
utue.publikation.abrufzeichen	tdis	de_DE
utue.publikation.swbdatum	2506	de_DE
utue.publikation.fachbereich	41	de_DE
utue.publikation.fakultaet	4	de_DE
utue.publikation.noppn	yes	de_DE
utue.artikel.ppn	1928525776	de_DE